Latest Headlines

Latest Headlines

Backlash rages on over Purdue's pediatric OxyContin approval

Back in August, the FDA approved Purdue's powerful painkiller, OxyContin, for children ages 11 to 16. But nearly two months later, the public backlash hasn't died down.

Judge halts lawsuit blaming Purdue, Endo and others for epidemic of drug abuse

It was attention-grabbing when California sued a handful of drugmakers, accusing them of lying about the safety of their high-powered painkillers and blaming them for an epidemic of prescription drug overdoses and a resurgence in heroin use. But from a legal standpoint, a California judge has ruled, there is not much there to stand on.

Purdue hones abuse-deterrent edge with painkiller safety campaign

When it comes to abuse-deterrent opioid painkillers, Purdue Pharma has the advantage--and it's touting that advantage with its latest marketing initiative.

FDA approves Purdue's controversial OxyContin for kids aged 11 to 16

Purdue Pharma now has FDA permission to market highly controversial opioid painkiller OxyContin to an even younger population.

Painkiller marketing secrets? Check Chicago's unredacted suit against Endo, Purdue, Cephalon, et al.

The city of Chicago made big news when it sued 5 drugmakers, alleging that their painkiller marketing broke the law. But much of the juicy detail in that lawsuit was hidden from view, redacted under a confidentiality agreement with the companies. Now, it's open for viewing.

Purdue hands California list of risky OxyContin prescribers

Which doctors to flag for reckless OxyContin prescribing may soon be a decision that's out of maker Purdue Pharma's hands, at least in California. Thursday, a spokesman from Purdue Pharma confirmed that the company had turned over a list of 49 California doctors it suspected of risky script-writing to the Medical Board of California.

California bills zero in on risky painkiller prescribers

California is pushing some new legislation that drugmakers and physicians were none too happy with in its original form. But after some amendments, a slate of reforms to increase authorities' powers to crack down on risky narcotics prescribers has made its way to the desk of Gov. Jerry Brown. The three bills now await his signature to make them law.

Lawmakers demand Purdue Pharma's list of suspect OxyContin prescribers

Now that Purdue Pharma has acknowledged news reports that it compiled a list of 1,800 doctors suspected of churning out OxyContin prescriptions  for addicts and drug dealers, the political fallout has begun.

LAT: Purdue keeps 'risky' OxyContin prescribers' names private

Purdue Pharma has a database of doctors who prescribe a lot of its painkiller OxyContin. On the face of it, that's not much of a statement, but in this case, the list of more than 1,800 comprises doctors suspected of recklessly writing scripts for addicts and drug dealers, the Los Angeles Times reports.

FDA halts generic OxyContin, handing Purdue a victory

For months FDA regulators have been wrestling with the dangers of allowing a flood of cheap, generic version of the highly addictive OxyContin on the market vs. consumers with pain issues having access to cheaper meds.